Science&Tech Some hope for Alzheimer’s disease treatment emerges By WeeklyNews staff Posted on December 6, 2019 1 min read Share on Facebook Share on Twitter Share on Google+ The American biotechnologist Biogen and his Japanese partner Eisai are making rapid progress with their experimental means for the treatment of Alzheimer’s disease. The new test results for aducanumab drug were labeled as a “milestone” by the research panel at a pharmaceutical conference in the United States. A high dose of aducanumab, taken for a long period of time, could have “some effectiveness” in Alzheimer’s treatment, the results showed. According to one of the experts in the research panel, the drug is the first treatment to tackle the root cause of Alzheimer’s. That opens the doors to conduct further research in this direction. In October, Biogen and Eisai decided to breathe new life into experimental drug testing. The two had just put an end to the investigations, after disappointing results. They turned out to be better than expected afterwards.